The motion, filed Sept. 18, is part of a lawsuit filed last month by Children’s Health Defense against the U.S. Food and Drug Administration’s approval of Pfizer’s Comirnaty Vaccine.
As I have said repeatedly, any society willing to place burdens on children to make adults feel better has lost its collective mind. In August, two FDA vaccine experts resigned, reportedly due to political pressure to approve boosters. Perhaps that is only half the story.
Our healthcare system is broken, a fact nobody would have disputed in precovid days. Regulatory capture is a reality, and the pharmaceutical industry is fraught with examples. Yet we trusted private-public partnerships to find an optimal solution to a global pandemic, assuming a crisis would bring out the best in historically corrupt institutions.
Five institutions will explore potential links between COVID vaccines and menstrual irregularities — research that wasn’t conducted during clinical trials, but is being done now, after thousands of women reported changes in their menstrual cycles post vaccination.
Two active duty members of the U.S. Armed Forces on Aug. 17 filed a lawsuit against the U.S. Department of Defense, U.S. Food and Drug Administration and U.S. Department of Health and Human Services on behalf of themselves and 220,000 active service members who are being forced to get a COVID vaccine despite having had COVID and acquired natural immunity to SARS-CoV-2.
In an exclusive interview with The Defender, Gianni Cohen said her mother, Cheryl Cohen, developed Creutzfeldt-Jakob Disease after getting the Pfizer vaccine, and died within three months of her second dose.
VAERS data released Friday by the CDC showed a total of 623,343 reports of adverse events from all age groups following COVID vaccines, including 13,627 deaths and 84,466 serious injuries between Dec. 14, 2020 and Aug. 20, 2021.
Pfizer CEO Albert Bourla told Fox News the company has a system in place to turn around a variant-specific jab within 95 days in the likelihood a vaccine-resistant COVID strain emerges, but experts warn that strategy will backfire.
